JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its first quarter 2015 investor conference webinar scheduled on June 9, 2015 at 16:00 (EET). Please note that attendees have to register for the webinar – detailed information on the registration process is available below.
During the webinar Salvis Lapins will inform about JSC Olainfarm latest activities and analyze the non-audited financial results of the first quarter 2015 and audited financial results of 2014. After the presentation investors are welcome to ask questions. During the webinar the enclosed presentation will be presented: Webinar Presentation: 1st quarter of 2015
How to join the webinar?
All you need is a computer with internet connection and headphones.
To join the webinar, we invite you to register via http://ej.uz/OLF_1Q2015.
You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds.
For more information on webinar service please visit: http://www.nasdaqbaltic.com/en/products-services/webinars-3/
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Member of the Board
Tel: +371 6 7013 717
Cell: +371 2 6448 873